Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299207 · ClinicalTrials.gov registry record
PITT PCI Xience Registry
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 2,506
- Enrollment target
NCT01299207: Completed study, sponsored by University of Pittsburgh.
NCT01299207 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 2,506 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01299207 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 2,506 participants
- Enrollment target
Study Summary
Stents are devices utilized to treat cholesterol blockages of the coronary (heart) arteries. The introduction of drug-eluting (coated) stents into clinical practice is regarded as a revolutionary breaktrhough, as it has reduced the incidence of re-narrowing of the arteries after percutaneous coronary interventions are performed. There has been, however, concerns of increased risk for clot formation in the heart arteries of patients treated with drug-eluting stents. Therefore, in order to lower the risk of clot formation, it is recommended that patients receiving these types of stents, be treated with dual antiplatelet therapy (blood thinning medication) for one year. The effect of this strategy, however, on clot formation and bleeding complications when utilizing "newer generation" stents, such as the Xience: Everolimus-eluting Stent, have not been well described. Therefore, the aim of this registry study is to evaluate the risk of adverse cardiovascular events, including mortality, non-fatal myocardial infarction, stent thrombosis, hemorrhagic stroke, and severe bleeding in relation to the timing and discontinuation of dual antiplatelet therapy in patients treated with Xience drug-eluting stents, and compare it to patients that do not discontinue dual antiplatelet therapy.
Primary Outcome
Combined end-point of all cause mortality, non-fatal myocardial infarction, stent thrombosis, need for repeat revascularization.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,506 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-12 |
What the finished NCT01299207 record still lists
NCT01299207 is an observational study that tracks outcomes without assigning an intervention. Its 2,506 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01299207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01299207 about?
NCT01299207 is a clinical study titled "PITT PCI Xience Registry". Stents are devices utilized to treat cholesterol blockages of the coronary (heart) arteries. The introduction of drug-eluting (coated) stents into clinical practice is regarded as a revolutionary breaktrhough, as it has reduced the incidence of re-narrowing of the arteries after percutaneous coronar...
What is the current status of trial NCT01299207?
This trial is currently completed. The enrollment target is 2,506 participants. The study started on 2011-08. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01299207?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia